Alpine Immune Sciences, Inc. clinical trials
Acquired by Vertex Pharmaceuticals Incorporated, May 18, 2024 · source ↗
The registry lists 10 studies whose lead sponsor is Alpine Immune Sciences, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Before and after it joined Vertex Pharmaceuticals Incorporated
- First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- 9
- First submitted after Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Alpine Immune Sciences, Inc.7 studies
- Alpine Immune Sciences Inc, A Subsidiary of Vertex3 studies
Something wrong with this grouping? Tell us on the Vertex Pharmaceuticals Incorporated page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Vertex Pharmaceuticals Incorporated studies →
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)CompletedNCT05757570Phase 1/2
Sponsor listed in the registry: Alpine Immune Sciences Inc, A Subsidiary of Vertex · First submitted before Alpine Immune Sciences Inc became part of Vertex Pharmaceuticals Incorporated
- Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)Active, not recruitingNCT06564142Phase 3
Sponsor listed in the registry: Alpine Immune Sciences Inc, A Subsidiary of Vertex · First submitted after Alpine Immune Sciences Inc became part of Vertex Pharmaceuticals Incorporated
- ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusCompletedNCT04835441Phase 2
Sponsor listed in the registry: Alpine Immune Sciences Inc, A Subsidiary of Vertex · First submitted before Alpine Immune Sciences Inc became part of Vertex Pharmaceuticals Incorporated
- ALPN-202 With PD-1 Inhibition in Advanced MalignanciesTerminatedNCT04920383Phase 1
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHDTerminatedNCT04227938Phase 1
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- An Open-label Study of ALPN-202 in Subjects With Advanced MalignanciesTerminatedNCT04186637Phase 1
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- A Study of ALPN-303 in Adult Healthy VolunteersCompletedNCT05034484Phase 1
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- Cell Surface Marker Expression in Autoimmune DiseasesCompletedNCT03757065
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated
- Adult Healthy Volunteers Study to Evaluate ALPN-101 SafetyCompletedNCT03748836Phase 1
Sponsor listed in the registry: Alpine Immune Sciences, Inc. · First submitted before Alpine Immune Sciences, Inc. became part of Vertex Pharmaceuticals Incorporated